Key indices were off day’s highs Thursday as profit booking emerged at higher levels. Sustained buying activity was seeen in metals, The outlook remains hazy as investors search new reasons to justify thei
r stand on equity investment. After a flat start, the indices will swing mostly to global cues. A recovery may be always on the cards but avoid getting in stocks which appear ripe after the recent run. The dangerous mid-caps may be back on the shopping list even though the risk-reward ratio remains lower for now.The results have been mostly on par or above expectations barring a few cement companies. Disinvestment (the buzzword for the bulls) may see action in mid-August as around 15 PSUs have been asked to give IPO feasibility report,” said India Infoline report. At 12:20 pm, Bombay Stock Exchange’s Sensex was at 15017.10, up 173.98 points or 1.17 per cent. The index touched an intra-day high of 15174.82 and low of 14997.75. National Stock Exchange’s Nifty was at 4456.70, up 57.80 points or 1.31 per cent. The broader index touched a high of 4501.95 and low of 4405.95.
r stand on equity investment. After a flat start, the indices will swing mostly to global cues. A recovery may be always on the cards but avoid getting in stocks which appear ripe after the recent run. The dangerous mid-caps may be back on the shopping list even though the risk-reward ratio remains lower for now.The results have been mostly on par or above expectations barring a few cement companies. Disinvestment (the buzzword for the bulls) may see action in mid-August as around 15 PSUs have been asked to give IPO feasibility report,” said India Infoline report. At 12:20 pm, Bombay Stock Exchange’s Sensex was at 15017.10, up 173.98 points or 1.17 per cent. The index touched an intra-day high of 15174.82 and low of 14997.75. National Stock Exchange’s Nifty was at 4456.70, up 57.80 points or 1.31 per cent. The broader index touched a high of 4501.95 and low of 4405.95.For Further Details Visit At:economictimes.indiatimes.com/Sensex-off-highs-Sun-Pharma-Bharti-down/articleshow/4810909.cms
No comments:
Post a Comment